Evidence map›Paper›PMID 41238165›Full record

Trial reportAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2026

Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium Trial.

Michael J Fischer, Jesse Y Hsu, Joanna Walsh, Kerri L Cavanaugh, David M Charytan, Susan T Crowley, Daniel Cukor, Laura M Dember, Ardith Z Doorenbos, Denise Esserman and 16 more

Abstract readClinical Trial, Phase IIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Michael J FischerDepartment of Medicine, University of Illinois-Chicago, Chicago, Illinois; Medical Service, Jesse Brown VA Medical Center, Chicago, Illinois; Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, Illinois. Electronic address: fischerm@uic.edu.
Jesse Y HsuDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Joanna WalshDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Kerri L CavanaughDepartment of Medicine, Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee.
David M CharytanNephrology Division, Department of Medicine, Grossman School of Medicine, New York University, New York; NYU Langone Health, New York, New York.
Susan T CrowleySection of Nephrology, Department of Medicine, School of Medicine, Yale University, New Haven, Connecticut; Kidney Medicine Program, Medical Services, VA Connecticut Healthcare System, West Haven, Connecticut.
Daniel CukorNephrology Division, Department of Medicine, Grossman School of Medicine, New York University, New York; NYU Langone Health, New York, New York.
Laura M DemberDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia; Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Ardith Z DoorenbosCollege of Nursing, University of Illinois-Chicago, Chicago, Illinois.
Denise EssermanDepartment of Biostatistics, School of Public Health, Yale University, New Haven, Connecticut.
Manisha JhambRenal-Electrolyte Division, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Kirsten L JohansenDepartment of Medicine, Medical School, University of Minnesota, Minneapolis; Nephrology Division, Hennepin Healthcare, Minneapolis, Minnesota.
Francis J KeefePain Prevention and Treatment Research Program, Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University, Durham, North Carolina.
Paul L KimmelDivision of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Mark B LockwoodDepartment of Behavioral Nursing Science, University of Illinois-Chicago, Chicago, Illinois.
Rajnish MehrotraKidney Research Institute, Division of Nephrology, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington.
Benjamin J MorascoDepartment of Psychiatry, Oregon Health and Science University, Portland, Oregon; Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon.
Sagar NigwekarDepartment of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Patrick PunDuke Clinical Research Institute, School of Medicine, Duke University, Durham, North Carolina; Durham Veteran Administration Medical Center, Durham, North Carolina.
Rudy QamhiyehDepartment of Medicine, Medical School, University of Minnesota, Minneapolis; General Internal Medicine, Minneapolis VA Health Care System, Minneapolis, Minnesota.
Jennifer S SchererNephrology Division, Department of Medicine, Grossman School of Medicine, New York University, New York; NYU Langone Health, New York, New York.
Rebecca SchmidtDivision of Nephrology, Department of Medicine, School of Medicine, West Virginia University, Morgantown, West Virginia.
Jennifer L SteelDepartment of Medicine, and Division of Hepatobiliary Surgery, Department of Surgery, Psychiatry, and Psychology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Mark L UnruhDivision of Nephrology, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, New Mexico; Research Service, Department of Medicine, Raymond G. Murphy Veterans Affairs Medical Center, Albuquerque, New Mexico.
Jonathan G YabesDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Sahir KalimDepartment of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

Funding

UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in Hemodialysis U01DK123813 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DEMBER, LAURA M, FARRAR, JOHN T · 2019 to 2024
$6.6M
Randomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER)U01DK123786 · NIDDK · UNIVERSITY OF WASHINGTON · PI CUKOR, DANIEL, MEHROTRA, RAJNISH · 2019 to 2022
$3.4M
Pain Reduction and Opioid MedIcation Safety in ESRD (PROMISE) studyU01DK123812 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JHAMB, MANISHA, LIEBSCHUTZ, JANE M · 2019 to 2020
$3.1M
University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical CenterU01DK123787 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOORENBOS, ARDITH Z, FISCHER, MICHAEL J. · 2019 to 2020
$3.0M
Pain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patientsU01DK123814 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHARYTAN, DAVID M, LEE, JOSHUA D · 2019 to 2019
$2.9M
Vanderbilt-West Virginia (VWV) Collaborative: A HOPE Consortium Clinical CenterU01DK123821 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAVANAUGH, KERRI · 2019 to 2019
$2.9M
The Hemodialysis Opioid Prescription Effort ConsortiumU01DK123816 · NIDDK · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI BART, GAVIN, JOHANSEN, KIRSTEN L. · 2019 to 2019
$2.6M
Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving HemodialysisU01DK123817 · NIDDK · YALE UNIVERSITY · PI BECKER, WILLIAM C, CROWLEY, SUSAN T · 2019 to 2019
$2.6M
Reducing Chronic Pain and Opioid Use in Hemodialysis PatientsU01DK123818 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KALIM, SAHIR, NIGWEKAR, SAGAR · 2019 to 2019
$2.4M
Expanding Multilevel Multicomponent Mentorship in Kidney Disease ResearchK26DK138374 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kerri Cavanaugh · 2023 to 2026
$562k
NIDDK NIH HHS K26 DK138374NIDDK NIH HHS U01 DK123786NIDDK NIH HHS U01 DK123787NIDDK NIH HHS U01 DK123812NIDDK NIH HHS U01 DK123813NIDDK NIH HHS U01 DK123814NIDDK NIH HHS U01 DK123816NIDDK NIH HHS U01 DK123817NIDDK NIH HHS U01 DK123818NIDDK NIH HHS U01 DK123821
6 · The paper itself

Abstract

RATIONALE &

objectiveAdults receiving maintenance hemodialysis (HD) frequently report pain, yet detailed descriptions of pain in this population are lacking. This study examines pain locations, characteristics, and associations with other symptoms in adults receiving HD. STUDY

designCross-sectional analysis. SETTING &

participantsAdults with moderate to severe chronic pain receiving maintenance HD enrolled in the multicenter HOPE Consortium Trial from 2021 to 2023. EXPOSURE: Sociodemographic, pain treatment, dialysis, medical comorbidity, and psychological and behavioral characteristics. Other patient-reported symptoms. OUTCOME: Pain interference and severity as assessed by the Brief Pain Inventory (BPI) Interference and Severity subscales (range, 0-10). ANALYTICAL APPROACH: Multivariable regression with least absolute shrinkage and selection operator (LASSO) to examine associations between participant characteristics and pain interference/severity, and Spearman's correlation to examine relationships between other symptoms and pain interference/severity at baseline.

resultsAmong 643 participants, the median BPI interference was 6.6 (IQR, 5.1-7.9) and severity was 6.0 (IQR, 4.5-7.5). Among the participants, 84% of participants reported pain >1 year, and 75% had daily pain; 89% and 66% of participants endorsed musculoskeletal and neuropathic pain, respectively. Of 32 body regions, the median number of painful regions was 8 (IQR, 4-14). Common regions in females were lower back (72%), knees (64%), legs (60%), and upper back (59%), and a similar pattern existed for males. In LASSO analyses, cardiovascular disease and depression were associated with significantly higher pain interference whereas White race (reference, Black race) and non-Hispanic ethnicity were associated with significantly lower pain interference. Similar findings were noted for pain severity. Pain catastrophizing and symptoms of fatigue, depression, and anxiety were moderately correlated with pain interference (r > 0.4). LIMITATIONS: Neither relationship directionality nor causality can be inferred.

conclusionsAmong adults treated with HD who have chronic pain, pain locations were numerous and diverse, with substantial musculoskeletal and neuropathic characteristics. Factors associated with pain interference were predominantly sociodemographic and psychological rather than those related to comorbid diseases and dialysis. PLAIN-LANGUAGE SUMMARY: Adults receiving maintenance hemodialysis (HD) frequently experience chronic pain, but it remains poorly understood. We examined pain locations, characteristics, and relationships with other symptoms among 643 adults with moderate to severe chronic pain receiving maintenance HD enrolled in the multicenter HOPE Consortium Trial from 2021 to 2023. We found that pain locations were numerous and diverse, with substantial musculoskeletal and neuropathic pain characteristics. The factors associated with pain interference were predominantly sociodemographic and psychological rather than related to comorbid diseases and dialysis. Given these findings, routine pain assessments and treatment plans tailored to the specific needs and symptoms of the individual patient seem warranted for this patient population.

Indexed as

Chronic PainKidney Failure, ChronicRenal DialysisAdultAgedCross-Sectional StudiesDepressionFemaleHumansMaleMiddle AgedPain MeasurementDepressiondialysispainsymptomstrial

Identifiers

PMID41238165
PMCPMC12776455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.